GratXray AG

The core activity of GratXray is the development, manufacture and marketing of systems for breast cancer diagnosis based on phase contrast-enhanced X-ray imaging. In particular, the company focuses on the development of imaging systems that enable precise and pain-free diagnosis of breast cancer without the need for breast compression or contrast agents.